US EditionArcheus Technologies Gets FDA Approval for ART-101 Application
Summary by Pharmaceutical Business Review
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
All
Left
Center
Right
Archeus Technologies gets FDA approval for ART-101 application
This new small molecule is designed for prostate cancer imaging and treatment. The FDA’s approval allows Archeus to begin a Phase I clinical study targeting metastatic castration-resistant prostate The post Archeus Technologies gets FDA approval for ART-101 application appeared first on Pharmaceutical Business review.
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
